Sugita K - Search Results

1

Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.

Uchida N, Yoshida H, Yamada H, Wada T, Daikatsu K, Ikeuchi I, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Jpn J Cancer Res. 1999 Aug;90(8):887-94. doi: 10.1111/j.1349-7006.1999.tb00831.x. Jpn J Cancer Res. 1999. PMID: 10543262 Free PMC article.

2

Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.

Uchida N, Kasai H, Takeda Y, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Anticancer Res. 1998 Jan-Feb;18(1A):247-52. Anticancer Res. 1998. PMID: 9568085

3

Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase.

Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, Sugita K. Yoshioka T, et al. Among authors: sugita k. Cancer Res. 1998 Jun 15;58(12):2583-7. Cancer Res. 1998. PMID: 9635582

4

Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.

Uchida N, Takeda Y, Kasai H, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Anticancer Res. 1998 Sep-Oct;18(5A):3375-9. Anticancer Res. 1998. PMID: 9858911

5

[Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].

Uchida N, Takeda Y, Kasai H, Hojo K, Wada T, Nishida K, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Gan To Kagaku Ryoho. 1998 Dec;25(14):2267-74. Gan To Kagaku Ryoho. 1998. PMID: 9881084 Japanese.

6

Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.

Uchida N, Takeda Y, Hojo K, Maekawa R, Sugita K, Yoshioka T. Uchida N, et al. Among authors: sugita k. Eur J Cancer. 1998 Oct;34(11):1796-801. doi: 10.1016/s0959-8049(98)00194-4. Eur J Cancer. 1998. PMID: 9893671

7

Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor.

Maekawa R, Maki H, Yoshida H, Hojo K, Tanaka H, Wada T, Uchida N, Takeda Y, Kasai H, Okamoto H, Tsuzuki H, Kambayashi Y, Watanabe F, Kawada K, Toda K, Ohtani M, Sugita K, Yoshioka T. Maekawa R, et al. Among authors: sugita k. Cancer Res. 1999 Mar 15;59(6):1231-5. Cancer Res. 1999. PMID: 10096553

8

Antitumor efficacy of hypothemycin, a new Ras-signaling inhibitor.

Tanaka H, Nishida K, Sugita K, Yoshioka T. Tanaka H, et al. Among authors: sugita k. Jpn J Cancer Res. 1999 Oct;90(10):1139-45. doi: 10.1111/j.1349-7006.1999.tb00688.x. Jpn J Cancer Res. 1999. PMID: 10595743 Free PMC article.

9

Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.

Takeda Y, Kasai H, Uchida N, Yoshida H, Maekawa R, Sugita K, Yoshioka T. Takeda Y, et al. Among authors: sugita k. Anticancer Res. 1999 Sep-Oct;19(5B):4059-64. Anticancer Res. 1999. PMID: 10628354

10

A novel tetracyclic peptide, trapoxin, induces phenotypic change from transformed to normal in sis-oncogene-transformed NIH3T3 cells.

Yoshida H, Sugita K. Yoshida H, et al. Among authors: sugita k. Jpn J Cancer Res. 1992 Apr;83(4):324-8. doi: 10.1111/j.1349-7006.1992.tb00109.x. Jpn J Cancer Res. 1992. PMID: 1506265 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,467 results

Search Page

Filters